Answers are grounded in this paper and cite their sources.
The development of novel anticancer agents remains a key focus in medicinal chemistry. We hypothesized that benzamide substitution of the 1,8-naphthyridine scaffold would enhance anticancer activity. In this study, we report a rapid, efficient, and environmentally benign green synthetic approach for the construction of a new series of N-(5,7-dimethyl-1,8-naphthyridin-2-yl)benzamide derivatives (5a-h). The synthesized compounds were characterized using standard spectroscopic techniques. All compounds were evaluated for their in vitro anticancer activity against three human cancer cell lines: MCF-7, A549, and Colo-205. The results revealed that the tested compounds exhibited significant anticancer activity. Among them, N-(5,7-dimethyl-1,8-naphthyridin-2-yl)-2-nitrobenzamide (5e) and 2-chloro-N-(5,7-dimethyl-1,8-naphthyridin-2-yl)benzamide (5c) showed the most potent activity, with IC50 values of 6.06 ± 0.14 μM (MCF-7), 8.36 ± 0.36 μM (A549), and 12.27 ± 0.73 μM (Colo-205) for compound 5e, and 8.06 ± 0.29 μM (MCF-7), 10.72 ± 0.49 μM (A549), and 15.39 ± 0.43 μM (Colo-205) for compound 5c, compared with the standard drug.
No takes yet. Share an insight, caveat, or question.
Venkatesh et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: